NZF-2 (MyT1) is a member of C2HC-type zinc finger transcription factors. A novel form of mouse NZF-2 has been isolated. This novel form, NZF-2b, has an additional C2HC-type zinc finger motif. The expression levels of NZF-2b are by far the more predominant than those of the already known form of NZF-2. In embryonic mouse nervous system, the expression of NZF-2b starts as early as at 9.5 days post-coitum (dpc) in newly differentiated neurons in the central nervous system (CNS) and the peripheral nervous system (PNS). q
Results and discussion
Neural zinc finger proteins (NZFs) are transcription factors with DNA-binding domains of a C2HC-type zinc finger motif (Jiang et al., 1996; Kim and Hudson, 1992; Weiner and Chun, 1997; Yee and Yu, 1998) . Xenopus NZF-2 (X-MyT1) has a regulatory function in neuronal differentiation (Bellefroid et al., 1996) . In mammals, the function of NZF-2 has been suggested mainly in relation with gliogenesis (Armstrong et al., 1995; Kim and Hudson, 1992) . Despite some indications that NZF-2 is also functional in neuronal differentiation in rat, the previous histological analysis of rat was limited to advanced stages of central nervous system (CNS) development (Kim et al., 1997) . Therefore, we focused on the expression of NZF-2 in early stages of neuronal differentiation in mammals. This work shows that NZF-2b, a novel predominant subtype of mouse NZF-2 with an additional zinc finger, is expressed in differentiated neurons especially at higher levels in newly generated ones.
Isolation of cDNA encoding NZF-2b
By using partial cDNA fragment of the already known form of mouse NZF-2/MyT1 (nucleotides (nt) 628-1155; Kim et al., 1997) as a probe, we isolated cDNAs encoding a novel subtype of mouse NZF-2 from embryonic mouse brain cDNA library (ICR, 17.5 dpc; Kameyama et al., 1996; Fig. 1A) . We designate this novel subtype as NZF-2b (DDBJ/GenBank accession number AB082378) and the already known form as NZF-2a. NZF-2b has an additional C2HC-type zinc finger motif at N-terminus, but otherwise is almost identical with NZF-2a (Fig. 1B, C) . In the databases, cDNA homologous to NZF-2b is found only in human (KIAA0835 gene; Nagase et al., 1998; Fig. 1B, C) , and cDNA homologous to NZF-2a is found in rat and Xenopus.
NZF-2b is a predominant form of mouse NZF-2
To investigate expressional differences of two types of NZF-2, we estimated the expression levels of both types of NZF-2 transcripts in the course of development by using quantitative real time reverse transcriptase-polymerase chain reaction (RT-PCR). The result reveals that the copy numbers of NZF-2b are by far the more predominant than those of NZF-2a in mRNA level at all stages of development and in adulthood (Fig. 2) . NZF-2a is expressed at extremely low levels. False detection of NZF-2a due to contamination of genomic DNA in the RT-PCR reaction is excluded because NZF-2a is not detected without reverse transcriptase.
Expression of NZF-2b in the spinal cord
We focused on the early stages of neuronal differentiation and analyzed the expression pattern of NZF-2b from 9.5 to 13.5 dpc mouse nervous system. NZF-2b transcripts are detected in the earliest born neurons. At 9.5 dpc, they are detected in the ventrolateral part of the spinal cord, which later become motor neurons (arrowhead in Fig. 3C ; Altman and Bayer, 1984; Garel et al., 1997) . They are also detected in the dispersed cells of the alar plate interneurons (arrows in Fig. 3C ). During spinal cord development, the expression level of NZF-2b is highest in the latest born neurons (the subventricular zone (SVZ); arrowheads in Fig. 3G, K) . In all stages analyzed, the signals of a probe specific to NZF-2b are almost identical with those of a probe common to compare Fig. 3B with C, etc) . No detectable signals are observed by using a probe specific to NZF-2a (Fig. 3D , H, L).
Expression of NZF-2b in the other CNS and the PNS
Not only in the spinal cord, but also in the other CNS and in the PNS, the signals of NZF-2com probe are almost identical with those of NZF-2b. In consequence, we used NZF2com probe to show further the expression of NZF-2b in the developing nervous system. NZF-2b transcripts are detected in the early differentiated neurons within the neuroepithelium and the neural crest cells at 9.5 dpc (data not shown). At 12.5 dpc, the transcripts of NZF-2b are detected in the differentiated neurons within the forebrain (Fig. 4A) , midbrain, and hindbrain (Fig. 4B) . In these neurons, the expression level of NZF-2b is highest in the latest born neurons (SVZ, arrows in Fig. 4A, B) . NZF-2b is also detected in the differentiated neurons of the sensory organs (Fig. 4C, D) and the peripheral ganglia (Fig. 4E, F) .
Methods

Real time RT-PCR analysis
Quantitative real time RT-PCR analysis was performed by LightCycler (Roche Diagnostics) with QuantiTect SYBR Green PCR kit (Quiagen). Total RNAs from various sources of ddy mice were used as templates for Omniscript reverse (Kim et al., 1997) , the probe that we used to screen, and the resultant isolated clones are shown. Respective open reading frames (ORFs) of NZF-2a and NZF-2b (clone 7N-3) are indicated by boxed arrows. The regions specific to NZF-2a and NZF-2b are shown in green and red, respectively. Note that all five isolated clones encode NZF-2b. (B) Structural comparison of mouse NZF-2 proteins. The black boxes and the hatched boxes indicate C2HC-type zinc finger units and the acidic domains, respectively. The specific regions are shown in the same way as in (A). Percentages of identity between NZF-2b and each of two other proteins are shown for their corresponding domains (set apart by straight lines). The entire NZF-2b protein shows 87% identity with NZF-2a (Kim et al., 1997) and 90% identity with the deduced product of human KIAA0835 cDNA (Nagase et al., 1998) . (C) Amino acid sequence alignment of N-terminal portion of mouse NZF-2a, NZF-2b, and the deduced protein of human KIAA0835 cDNA clone. Identical residues are shown by shaded boxes. The conserved cysteine and histidine residues that constitute the C2HC-type zinc finger are indicated by asterisks. Fig. 3 . The expression of NZF-2b within developing spinal cord by RNA in situ hybridization. Transverse sections of 9.5 dpc (A-D), 11.5 dpc (E-H), and 13.5 dpc (I-L) spinal cord hybridized with indicated probes or immunostained with TuJ1 (Sigma), a monoclonal antibody against neuron-specific class III b-tubulin, which detects differentiated neurons (Easter et al., 1993) are shown. At 9.5 dpc, NZF-2b transcripts are detected in the earliest born neurons (an arrowhead and arrows in C). At 11.5 dpc, NZF-2b is expressed at high levels in the SVZ (arrowheads in G), at low levels in the ML, and at very low levels in the differentiated MN. At 13.5 dpc, NZF-2bis expressedin the SVZ andthe ML, at higherlevelsin the SVZ ofthe alarplate(arrowheadsin K). NomRNAis detectedin the whitematter.DRG, dorsal root ganglia; ML, mantle layer; MN, motor neurons; SVZ, subventricular zone; VZ, ventricular zone; WM, white matter. Scale bar, 0.1 mm (A-L). (NZF-2com, open bars) . At all stages quantified, the copy numbers of NZF-2b transcripts are almost equal to those of NZF-2com transcripts and are more than 65-fold excess of those of NZF-2a transcripts. The expression levels of NZF-2b have a peak at 15.5 dpc and keep low in adulthood. Transcripts were quantified by comparison with simultaneous standard reactions against linearized plasmids containing cDNAs of respective targets. The final copy number of transcripts shown in vertical axis was normalized with 2.0 £ 10 5 molecules of transcripts of the house keeping gene glyceraldehydes-3-phosphate dehydrogenase (GAPDH), which correspond to the copy number in about 10 ng total RNAs. The sources of total RNAs were heads at 10.5 dpc, whole brains at 12.5, 15.5, and 18.5 dpc, and also whole brains at postnatal day 2 (P2), P7, P14, P21 and adult mice. The error bars indicate the standard error.
transcriptase (Quiagen). Sets of primers for NZF-2com (5 0 -
give specific RT-PCR products of 102, 128, 106, and 121 bp, respectively.
In situ hybridization and immunohistochemistry
Serial paraffin sections (10 mm) were processed. NZF2com probe was a mixed probe made from two fragments of NZF-2b cDNA: one, nt 1947-2801, which separates the two zinc finger clusters, and the other corresponding to nt 3790-5510 of the 3 0 untranslated region. The two subtypespecific probes were made from fragments corresponding to nt 5-774 of NZF-2a cDNA and to nt 1-788 of NZF-2b cDNA. Fig. 4 . In situ hybridization with NZF-2com probe in 12.5 dpc mouse embryo. Coronal sections of forebrain (A), midbrain and hindbrain (B), eye (C), nasal cavity (D), and peripheral ganglia (E,F) are shown. In all figures, dorsal is to the top. The expression level of NZf-2b is especially high in the subventricular zone (arrows in A and B). AP, anterior pons; BG, basal ganglia; CBL, cerebellar primordium; CTX, cortex; Med, medulla; HT, hypothalamus; IS, isthmus; OE, olfactory epithelium; RE, respiratory epithelium; RET, retina; SC, superior colliculus; SCG, superior cervical sympathetic ganglion; ST, sympathetic trunk; TG, tegmentum; TH, thalamus; VNO, vomeronasal organ; Vg, trigeminal ganglion; VIIg, facial ganglion; VIIIg, vestibulocochlear ganglion; IXg, inferior ganglion of glossopharyngeal (IX) nerve; Xg-XIg, superior ganglion of vagus (X)-cranial accessory (XI) ganglion complex. Scale bars: 0.5 mm (A,B); 0.1 mm (C-F).
